The working group of the task force was carefully selected to have no expertise in breast cancer imaging, diagnosis or treatment. I was invited to be an expert to the evidence review panel, which is the group that looks at the evidence and provides it to the working group to inform their recommendation.
On June 13th, 2024. See this statement in context.